Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
165
9.310
Why?
Cystectomy
31
2024
51
5.960
Why?
Prostatic Neoplasms
43
2024
399
4.830
Why?
Kidney Neoplasms
22
2018
182
2.620
Why?
Carcinoma, Transitional Cell
13
2023
54
2.550
Why?
Prostatectomy
22
2023
84
2.240
Why?
Nephrectomy
19
2016
82
1.890
Why?
Lymph Node Excision
7
2024
133
1.740
Why?
Urinary Diversion
6
2021
43
1.550
Why?
Prostate
14
2024
117
1.460
Why?
Laparoscopy
13
2014
181
1.460
Why?
Quality of Life
12
2023
881
1.380
Why?
Aged
81
2024
10193
1.260
Why?
Male
120
2024
26794
1.180
Why?
Middle Aged
87
2024
13084
1.130
Why?
Humans
149
2024
52469
1.120
Why?
Neoadjuvant Therapy
12
2024
123
1.080
Why?
Neoplasm Staging
25
2024
765
0.970
Why?
BCG Vaccine
7
2024
16
0.930
Why?
Robotics
8
2015
43
0.920
Why?
Postoperative Complications
15
2021
1080
0.870
Why?
Retrospective Studies
52
2024
6643
0.870
Why?
Carcinoma, Renal Cell
10
2016
112
0.860
Why?
Penile Neoplasms
3
2024
45
0.840
Why?
Exercise Therapy
1
2023
100
0.780
Why?
Ureter
3
2016
36
0.780
Why?
Exercise
2
2023
548
0.760
Why?
Hernia
2
2020
7
0.730
Why?
Neoplasm Recurrence, Local
15
2024
638
0.680
Why?
Intestine, Small
2
2020
115
0.680
Why?
Treatment Outcome
30
2024
5471
0.660
Why?
Physical Fitness
1
2020
57
0.650
Why?
Herniorrhaphy
1
2020
34
0.650
Why?
Intestinal Obstruction
1
2020
38
0.650
Why?
Patient Readmission
6
2021
246
0.640
Why?
Image-Guided Biopsy
6
2024
34
0.620
Why?
Aged, 80 and over
26
2024
3413
0.620
Why?
Watchful Waiting
7
2019
28
0.610
Why?
Biopsy
17
2023
602
0.580
Why?
Neoplasm Invasiveness
14
2024
277
0.570
Why?
Ureteral Neoplasms
2
2018
11
0.570
Why?
Female
59
2024
28192
0.550
Why?
Testicular Neoplasms
4
2024
46
0.530
Why?
Magnetic Resonance Imaging
10
2023
1536
0.520
Why?
Urinary Bladder
7
2018
101
0.520
Why?
Convalescence
1
2016
6
0.510
Why?
Carcinoma, Squamous Cell
4
2024
330
0.500
Why?
Neoplasms, Germ Cell and Embryonal
3
2024
20
0.480
Why?
Prospective Studies
17
2024
2449
0.470
Why?
Urothelium
4
2018
19
0.460
Why?
Carcinoma in Situ
4
2024
72
0.460
Why?
Chemotherapy, Adjuvant
8
2024
122
0.460
Why?
Ileum
1
2014
88
0.440
Why?
Urologic Neoplasms
3
2019
12
0.440
Why?
Choline
3
2019
64
0.430
Why?
Neoplasm Grading
13
2020
125
0.430
Why?
Medical Oncology
4
2021
103
0.420
Why?
Quality Indicators, Health Care
1
2013
91
0.380
Why?
Needles
3
2021
25
0.380
Why?
Administration, Intravesical
7
2024
16
0.370
Why?
Urologic Surgical Procedures
3
2016
30
0.370
Why?
Disease Progression
8
2024
872
0.370
Why?
Lymphatic Metastasis
4
2024
210
0.370
Why?
Antineoplastic Agents
3
2021
1217
0.360
Why?
Biopsy, Needle
5
2021
182
0.350
Why?
Prostate-Specific Antigen
8
2021
44
0.350
Why?
Survival Rate
9
2021
949
0.350
Why?
Testicular Diseases
1
2011
11
0.350
Why?
Risk Assessment
10
2019
1348
0.340
Why?
Tumor Burden
6
2016
133
0.340
Why?
Urogenital Neoplasms
1
2010
9
0.340
Why?
Muscle Neoplasms
1
2010
16
0.330
Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.330
Why?
Registries
4
2023
629
0.320
Why?
Fluorine Radioisotopes
2
2019
25
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1025
0.310
Why?
Retroperitoneal Space
5
2016
26
0.310
Why?
Recovery of Function
2
2023
201
0.310
Why?
Adult
27
2024
14151
0.310
Why?
Psoas Muscles
2
2021
2
0.310
Why?
Self Report
1
2010
215
0.310
Why?
Organ Sparing Treatments
4
2018
57
0.300
Why?
Telomerase
2
2019
26
0.290
Why?
Patient Selection
5
2019
266
0.290
Why?
Urinary Incontinence
3
2023
40
0.280
Why?
Deoxycytidine
3
2024
26
0.280
Why?
Seat Belts
2
2017
17
0.270
Why?
Child Restraint Systems
2
2017
18
0.270
Why?
Urinary Catheterization
1
2007
24
0.270
Why?
Urethral Stricture
1
2007
23
0.270
Why?
Positron-Emission Tomography
2
2019
302
0.270
Why?
Time Factors
13
2020
2989
0.270
Why?
Primary Health Care
1
2011
375
0.270
Why?
Rectum
2
2024
55
0.260
Why?
Cohort Studies
8
2021
1550
0.260
Why?
Tomography, X-Ray Computed
3
2021
1162
0.250
Why?
Guideline Adherence
3
2017
143
0.250
Why?
Length of Stay
6
2020
672
0.250
Why?
Health Status
2
2015
299
0.250
Why?
Patient Discharge
3
2017
326
0.240
Why?
Pain Measurement
2
2017
256
0.240
Why?
Patient Participation
2
2016
69
0.230
Why?
Kidney
4
2014
722
0.230
Why?
Bandages
1
2005
28
0.230
Why?
Carcinoma
2
2018
137
0.230
Why?
Adenoviridae
2
2024
47
0.230
Why?
Surgical Wound Infection
1
2005
117
0.230
Why?
Neurilemmoma
1
2004
24
0.220
Why?
Age Factors
7
2021
1131
0.220
Why?
Antimetabolites, Antineoplastic
1
2024
38
0.220
Why?
Multivariate Analysis
8
2016
602
0.220
Why?
Quality Improvement
3
2016
224
0.220
Why?
Adenocarcinoma
3
2016
402
0.220
Why?
Immunohistochemistry
5
2024
980
0.220
Why?
Organoids
1
2024
39
0.220
Why?
Venous Thrombosis
1
2005
90
0.210
Why?
Perineum
1
2024
26
0.210
Why?
Follow-Up Studies
9
2024
2288
0.210
Why?
Antibiotic Prophylaxis
1
2024
61
0.210
Why?
Decision Making
2
2016
282
0.210
Why?
Clinical Competence
3
2016
399
0.200
Why?
Practice Guidelines as Topic
2
2018
496
0.200
Why?
Urethra
3
2014
98
0.190
Why?
Prognosis
9
2021
2113
0.190
Why?
Erectile Dysfunction
3
2023
93
0.190
Why?
United States
12
2020
5225
0.190
Why?
DNA, Neoplasm
2
2018
146
0.180
Why?
Logistic Models
7
2021
932
0.180
Why?
Vital Statistics
1
2021
3
0.180
Why?
Feasibility Studies
2
2020
403
0.180
Why?
Mandatory Reporting
1
2021
12
0.180
Why?
Death Certificates
1
2021
18
0.180
Why?
DNA Mutational Analysis
3
2018
180
0.180
Why?
Birth Certificates
1
2021
26
0.180
Why?
Cell Transdifferentiation
1
2021
8
0.180
Why?
Cost-Benefit Analysis
2
2019
269
0.180
Why?
Neuroendocrine Cells
1
2021
9
0.170
Why?
Reproducibility of Results
7
2018
1216
0.170
Why?
Urethral Diseases
2
2013
7
0.170
Why?
Radiosurgery
1
2022
129
0.170
Why?
Radiography, Abdominal
1
2020
25
0.170
Why?
Mutation
5
2019
1339
0.170
Why?
Reimbursement, Incentive
1
2020
12
0.170
Why?
Genetic Vectors
1
2020
130
0.170
Why?
Randomized Controlled Trials as Topic
4
2023
599
0.160
Why?
Ablation Techniques
1
2019
19
0.160
Why?
Genetic Therapy
1
2020
124
0.160
Why?
Abdominal Pain
1
2020
85
0.160
Why?
Diagnosis, Differential
2
2020
1044
0.150
Why?
Venous Thromboembolism
1
2020
76
0.150
Why?
Genetic Predisposition to Disease
5
2024
528
0.150
Why?
Adjuvants, Immunologic
3
2024
52
0.150
Why?
Urinary Tract
1
2018
25
0.150
Why?
Lymphocytes
1
2019
148
0.150
Why?
Forecasting
1
2019
154
0.150
Why?
Predictive Value of Tests
6
2018
944
0.150
Why?
Obesity
2
2006
1164
0.150
Why?
Genetic Heterogeneity
1
2018
20
0.150
Why?
Patient-Centered Care
1
2020
140
0.150
Why?
RNA, Neoplasm
1
2018
45
0.150
Why?
Neutrophils
1
2019
147
0.150
Why?
Drug Resistance, Neoplasm
1
2020
327
0.140
Why?
Internship and Residency
2
2021
438
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
41
0.140
Why?
Retroperitoneal Neoplasms
1
2018
18
0.140
Why?
Orchiectomy
1
2018
38
0.140
Why?
Transurethral Resection of Prostate
1
2018
10
0.140
Why?
Pain, Postoperative
2
2016
169
0.140
Why?
Body Size
1
2017
33
0.140
Why?
Quality Assurance, Health Care
1
2018
149
0.140
Why?
Physician-Patient Relations
2
2016
144
0.140
Why?
Inguinal Canal
1
2017
11
0.140
Why?
Urodynamics
2
2014
23
0.140
Why?
Sarcosine
1
2017
3
0.130
Why?
Anticoagulants
1
2020
277
0.130
Why?
Amino Acid Transport Systems
1
2017
5
0.130
Why?
Databases, Factual
2
2021
715
0.130
Why?
Electronic Health Records
1
2020
269
0.130
Why?
Body Height
1
2017
67
0.130
Why?
Carbon Radioisotopes
1
2017
54
0.130
Why?
Safety
1
2017
80
0.130
Why?
Guidelines as Topic
1
2017
110
0.130
Why?
Disease-Free Survival
5
2016
463
0.130
Why?
Transcriptome
2
2018
367
0.130
Why?
Replantation
1
2016
11
0.130
Why?
Scrotum
2
2015
31
0.130
Why?
Protons
1
2017
71
0.130
Why?
Nomograms
1
2016
7
0.130
Why?
Laparotomy
1
2016
37
0.130
Why?
Natural Orifice Endoscopic Surgery
1
2016
5
0.130
Why?
Research Report
1
2016
18
0.120
Why?
Physicians
2
2016
240
0.120
Why?
Kaplan-Meier Estimate
5
2017
483
0.120
Why?
Urinary Retention
2
2007
7
0.120
Why?
Patient Preference
1
2016
43
0.120
Why?
Ureteral Obstruction
1
2016
62
0.120
Why?
Checklist
1
2016
40
0.120
Why?
Time-to-Treatment
1
2016
78
0.120
Why?
Preoperative Period
3
2021
47
0.120
Why?
Sensitivity and Specificity
5
2018
883
0.120
Why?
Genital Neoplasms, Male
1
2015
2
0.120
Why?
Paget Disease, Extramammary
1
2015
5
0.120
Why?
Social Networking
1
2015
16
0.120
Why?
Body Weight
1
2017
522
0.120
Why?
Lymph Nodes
1
2017
252
0.120
Why?
Feedback
1
2015
52
0.110
Why?
Radiopharmaceuticals
1
2016
204
0.110
Why?
Video Recording
1
2015
79
0.110
Why?
Treatment Failure
2
2017
122
0.110
Why?
Informed Consent
1
2015
96
0.110
Why?
Peer Group
1
2015
58
0.110
Why?
Proto-Oncogene Proteins B-raf
1
2015
77
0.110
Why?
Papilloma, Inverted
1
2014
1
0.110
Why?
Equipment Design
3
2021
290
0.110
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
68
0.110
Why?
Computer Simulation
1
2015
290
0.110
Why?
Blood Loss, Surgical
5
2016
69
0.110
Why?
Matched-Pair Analysis
1
2013
11
0.110
Why?
Urinary Incontinence, Stress
1
2014
32
0.110
Why?
Adenoma
1
2015
113
0.100
Why?
Kidney Diseases
1
2016
231
0.100
Why?
Diffusion of Innovation
1
2013
47
0.100
Why?
Carcinoma, Papillary
1
2014
51
0.100
Why?
General Surgery
1
2015
105
0.100
Why?
Body Mass Index
3
2020
691
0.100
Why?
Technology Transfer
1
2013
2
0.100
Why?
Mitomycin
1
2013
19
0.100
Why?
Longitudinal Studies
2
2018
746
0.100
Why?
Radiotherapy, Adjuvant
2
2018
63
0.100
Why?
Accreditation
1
2013
62
0.100
Why?
Severity of Illness Index
2
2014
1038
0.100
Why?
Peripheral Nerves
1
2013
44
0.100
Why?
Education, Medical, Continuing
1
2013
72
0.100
Why?
Operating Rooms
1
2012
27
0.090
Why?
Community Health Centers
1
2012
30
0.090
Why?
Pathology, Clinical
1
2012
25
0.090
Why?
Referral and Consultation
2
2012
292
0.090
Why?
Receptors, Androgen
2
2002
47
0.090
Why?
Algorithms
1
2015
669
0.090
Why?
Combined Modality Therapy
3
2021
638
0.090
Why?
Neoplasms
1
2021
1302
0.090
Why?
Risk Factors
5
2017
3945
0.090
Why?
Perioperative Care
1
2011
43
0.090
Why?
Seminal Vesicles
2
2022
13
0.080
Why?
Skin Neoplasms
1
2015
500
0.080
Why?
Phantoms, Imaging
2
2020
119
0.080
Why?
Multicenter Studies as Topic
2
2023
112
0.080
Why?
Medicare
3
2020
274
0.080
Why?
Proportional Hazards Models
3
2016
442
0.080
Why?
Markov Chains
2
2019
29
0.070
Why?
Carboplatin
2
2022
56
0.070
Why?
Immunotherapy
1
2010
243
0.070
Why?
SEER Program
3
2014
103
0.070
Why?
Postoperative Care
2
2020
102
0.070
Why?
Healthcare Disparities
1
2011
300
0.070
Why?
Ureteroscopy
1
2007
10
0.070
Why?
Automobiles
2
2017
13
0.070
Why?
Pandemics
2
2023
586
0.070
Why?
Sarcopenia
2
2021
98
0.070
Why?
Incidence
2
2021
1076
0.070
Why?
Chi-Square Distribution
3
2013
294
0.070
Why?
Diverticulum
1
2007
21
0.070
Why?
Peritoneum
1
2007
16
0.070
Why?
Cisplatin
2
2022
284
0.070
Why?
Delphi Technique
2
2018
64
0.070
Why?
Gene Amplification
2
2018
58
0.070
Why?
Aftercare
2
2018
72
0.070
Why?
Societies, Medical
2
2018
202
0.070
Why?
Adrenalectomy
1
2006
31
0.060
Why?
Gene Expression Profiling
2
2024
1108
0.060
Why?
Promoter Regions, Genetic
2
2019
474
0.060
Why?
Postoperative Hemorrhage
1
2006
54
0.060
Why?
Case-Control Studies
3
2014
1198
0.060
Why?
Fibrin Tissue Adhesive
1
2005
13
0.060
Why?
Sex Factors
2
2020
731
0.060
Why?
Hand
1
2005
51
0.060
Why?
Tissue Adhesives
1
2005
15
0.060
Why?
Genomics
2
2018
270
0.060
Why?
Intestines
1
2006
154
0.060
Why?
Suture Techniques
1
2005
58
0.060
Why?
Diabetes Complications
1
2005
125
0.060
Why?
Renal Insufficiency
1
2005
114
0.060
Why?
Chromosomes, Human, Pair 12
1
2024
14
0.050
Why?
Glomerular Filtration Rate
2
2016
129
0.050
Why?
Drug Screening Assays, Antitumor
1
2024
136
0.050
Why?
Vulnerable Populations
1
2024
52
0.050
Why?
Superior Mesenteric Artery Syndrome
1
2004
3
0.050
Why?
Mediastinal Neoplasms
1
2024
18
0.050
Why?
Communication
2
2016
257
0.050
Why?
Intraoperative Complications
1
2005
113
0.050
Why?
Hernia, Inguinal
1
2004
22
0.050
Why?
Phenotype
2
2018
799
0.050
Why?
High-Throughput Nucleotide Sequencing
2
2015
179
0.050
Why?
Cell Line, Tumor
2
2018
1423
0.050
Why?
Neoplasms, Second Primary
1
2024
77
0.050
Why?
Child
3
2024
7188
0.050
Why?
Quality of Health Care
2
2015
188
0.050
Why?
Papillomavirus Infections
2
2015
171
0.050
Why?
Ischemia
1
2004
154
0.050
Why?
Perioperative Period
2
2013
21
0.050
Why?
Trinucleotide Repeats
1
2002
4
0.050
Why?
Chromosome Aberrations
1
2024
297
0.050
Why?
Liver Cirrhosis
1
2005
243
0.050
Why?
Muscles
1
2022
108
0.050
Why?
Odds Ratio
2
2014
565
0.050
Why?
Polymorphism, Restriction Fragment Length
1
2002
66
0.050
Why?
Smoking
1
2005
517
0.050
Why?
Gallium Isotopes
1
2021
2
0.050
Why?
Accidents, Traffic
2
2017
90
0.050
Why?
Gallium Radioisotopes
1
2021
10
0.050
Why?
Edetic Acid
1
2021
14
0.050
Why?
Radiotherapy, Intensity-Modulated
2
2013
182
0.050
Why?
Androgen Antagonists
1
2021
11
0.050
Why?
Geography
1
2021
66
0.050
Why?
Polymorphism, Single Nucleotide
1
2024
507
0.040
Why?
Quarantine
1
2021
11
0.040
Why?
Public Health
1
2023
222
0.040
Why?
Internationality
1
2021
46
0.040
Why?
Neoplasm Metastasis
2
2017
237
0.040
Why?
Drug Dosage Calculations
1
2020
11
0.040
Why?
Motion
1
2020
19
0.040
Why?
Enoxaparin
1
2020
31
0.040
Why?
Finite Element Analysis
1
2020
11
0.040
Why?
Drug Monitoring
1
2020
82
0.040
Why?
Fellowships and Scholarships
1
2021
124
0.040
Why?
Pelvis
1
2020
67
0.040
Why?
Abdomen
1
2020
73
0.040
Why?
DNA-Directed RNA Polymerases
1
2019
12
0.040
Why?
Young Adult
2
2024
4326
0.040
Why?
Heparin
1
2020
87
0.040
Why?
Postoperative Period
1
2020
170
0.040
Why?
Social Behavior
1
2019
73
0.040
Why?
Urine
1
2018
25
0.040
Why?
Cytodiagnosis
1
2018
42
0.040
Why?
Adolescent
2
2024
6708
0.040
Why?
Diagnostic Errors
1
2018
69
0.040
Why?
Single-Blind Method
1
2018
116
0.040
Why?
DNA Copy Number Variations
1
2018
117
0.040
Why?
Genome, Human
1
2018
121
0.040
Why?
Quality-Adjusted Life Years
1
2018
67
0.030
Why?
Image Processing, Computer-Assisted
1
2019
243
0.030
Why?
Sequence Analysis, RNA
1
2018
99
0.030
Why?
Random Allocation
1
2018
285
0.030
Why?
Delivery of Health Care, Integrated
1
2018
49
0.030
Why?
Health Services Accessibility
2
2012
438
0.030
Why?
Hospitalization
2
2017
749
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1372
0.030
Why?
Nephrons
1
2016
6
0.030
Why?
Tissue Distribution
1
2017
173
0.030
Why?
Consensus
1
2018
191
0.030
Why?
Hospital Communication Systems
1
2016
5
0.030
Why?
Coitus
1
2016
18
0.030
Why?
Failure to Thrive
1
2016
19
0.030
Why?
Salvage Therapy
1
2017
136
0.030
Why?
Anastomosis, Surgical
1
2016
69
0.030
Why?
Radiometry
1
2017
127
0.030
Why?
Creatinine
1
2016
159
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Early Detection of Cancer
1
2018
184
0.030
Why?
Cyclin-Dependent Kinase 4
1
2015
10
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2015
12
0.030
Why?
Genes, erbB-1
1
2015
9
0.030
Why?
Operative Time
1
2016
77
0.030
Why?
Tape Recording
1
2015
7
0.030
Why?
Fever
1
2016
113
0.030
Why?
Socioeconomic Factors
2
2011
606
0.030
Why?
Learning Curve
1
2015
19
0.030
Why?
Groin
1
2015
16
0.030
Why?
Tissue Array Analysis
1
2015
46
0.030
Why?
Oncology Service, Hospital
1
2014
14
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
48
0.030
Why?
Vinblastine
1
2014
22
0.030
Why?
Europe
1
2014
91
0.030
Why?
North America
1
2014
76
0.030
Why?
Regression Analysis
1
2015
401
0.030
Why?
Incontinence Pads
1
2014
2
0.030
Why?
In Situ Hybridization
1
2014
68
0.030
Why?
Amino Acid Substitution
1
2014
79
0.030
Why?
Personal Satisfaction
1
2014
75
0.030
Why?
Kidney Failure, Chronic
1
2016
215
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
853
0.030
Why?
Gene Dosage
1
2014
78
0.030
Why?
Ultrasonography
1
2016
423
0.030
Why?
Methotrexate
1
2014
77
0.030
Why?
United States Department of Veterans Affairs
1
2015
293
0.030
Why?
Papillomaviridae
1
2014
104
0.030
Why?
Survivors
1
2014
118
0.030
Why?
Anxiety
1
2016
301
0.030
Why?
Dysuria
1
2013
1
0.030
Why?
Anesthesiology
1
2014
37
0.030
Why?
Cluster Analysis
1
2014
232
0.030
Why?
Prevalence
1
2016
1016
0.030
Why?
Intention to Treat Analysis
1
2013
30
0.030
Why?
Sequence Analysis, DNA
1
2014
230
0.030
Why?
Valsalva Maneuver
1
2013
10
0.030
Why?
Stents
1
2016
372
0.030
Why?
Diagnostic Tests, Routine
1
2013
31
0.020
Why?
Paclitaxel
1
2013
89
0.020
Why?
Health Services Research
1
2013
153
0.020
Why?
Doxorubicin
1
2014
241
0.020
Why?
Confidence Intervals
1
2013
159
0.020
Why?
Antibiotics, Antineoplastic
1
2013
79
0.020
Why?
Neutropenia
1
2013
115
0.020
Why?
Thrombocytopenia
1
2013
91
0.020
Why?
Survival Analysis
1
2014
671
0.020
Why?
Attitude of Health Personnel
1
2015
360
0.020
Why?
Angiomyolipoma
1
2012
10
0.020
Why?
Unnecessary Procedures
1
2012
20
0.020
Why?
Neoplasm, Residual
1
2013
173
0.020
Why?
Tertiary Care Centers
1
2012
83
0.020
Why?
Pilot Projects
1
2014
719
0.020
Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
Why?
Biopsy, Fine-Needle
1
2012
104
0.020
Why?
Patient Positioning
1
2011
31
0.020
Why?
Urination Disorders
1
2010
23
0.020
Why?
Disease Management
1
2012
186
0.020
Why?
Organ Size
1
2010
231
0.020
Why?
Comorbidity
1
2012
631
0.020
Why?
Health Status Disparities
1
2011
216
0.020
Why?
Intraoperative Period
1
2007
46
0.020
Why?
Erythrocyte Transfusion
1
2006
53
0.020
Why?
Costs and Cost Analysis
1
2006
96
0.020
Why?
Decision Trees
1
2005
22
0.010
Why?
Portal System
1
2005
17
0.010
Why?
Collateral Circulation
1
2005
38
0.010
Why?
Hypertension, Portal
1
2005
23
0.010
Why?
Reoperation
1
2006
464
0.010
Why?
Blood Transfusion
1
2005
129
0.010
Why?
Short Bowel Syndrome
1
2004
17
0.010
Why?
Necrosis
1
2004
170
0.010
Why?
Liver Transplantation
1
2005
165
0.010
Why?
Polymorphism, Genetic
1
2002
184
0.010
Why?
Genetic Markers
1
2002
108
0.010
Why?
Statistics, Nonparametric
1
2002
195
0.010
Why?
Base Sequence
1
2002
634
0.010
Why?
Polymerase Chain Reaction
1
2002
459
0.010
Why?
Molecular Sequence Data
1
2002
770
0.010
Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description